Literature DB >> 8129158

The physiology and pharmacology of postoperative nausea and vomiting.

R J Naylor1, F C Inall.   

Abstract

The main function of emesis is to remove toxins from the body. The emetic response will also be triggered by cancer chemotherapy and radiotherapy or surgery under general anaesthesia. The mechanism of activation of the vomiting system is dependent on stimulation of gastrointestinal (mechanoreceptors and chemoreceptors) and/or central pathways which activate the chemoreceptor trigger zone in the area postrema. Postoperative emesis is activated by a range of factors before, during and after anaesthesia. The precise mechanism of action of any one of the influencing factors can only be speculated as there has been very little basic research into this area, due largely to the lack of an appropriate model for postoperative nausea and vomiting. The range of agents used in the prevention and treatment of emesis are effective to varying degrees, but some are associated with poor side effect profiles making them particularly unsuitable for prophylactic use. Newer antiemetics, which selectively antagonise 5-HT3 receptors, have proved effective and well tolerated in the treatment of chemotherapy-induced emesis and postoperative nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129158     DOI: 10.1111/j.1365-2044.1994.tb03575.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Is recall of dreaming during anesthesia a sign of occurrence of postoperative nausea and vomiting?

Authors:  Tomonori Matsuyama; Hiroshi Iranami; Keisuke Fujii; Michiko Hirayama; Kouhei Kawashima
Journal:  J Anesth       Date:  2013-06-21       Impact factor: 2.078

2.  Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.

Authors:  M Rieck; A F Schumacher-Schuh; V Altmann; S M Callegari-Jacques; C R M Rieder; M H Hutz
Journal:  Pharmacogenomics J       Date:  2016-10-25       Impact factor: 3.550

Review 3.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 4.  Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?

Authors:  Tong J Gan
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Emergency open cholecystectomy is associated with markedly lower incidence of postoperative nausea and vomiting (PONV) than elective open cholecystectomy: a retrospective cohort study.

Authors:  Jeffrey M East; Derek I G Mitchell
Journal:  BMC Surg       Date:  2010-02-12       Impact factor: 2.102

6.  Preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a prospective, randomized, double-blind study.

Authors:  Mustafa Arslan; Ramazan Ciçek; Hülya Üstün Kalender; Hüseyin Yilmaz
Journal:  Curr Ther Res Clin Exp       Date:  2011-02

7.  Prophylactic antiemetic effects of Midazolam, Ondansetron, and their combination after middle ear surgery.

Authors:  Azim Honarmand; Mohammadreza Safavi; Mansoureh Chegeni; Anahita Hirmanpour; Masoud Nazem; Seyyad Hamid Sarizdi
Journal:  J Res Pharm Pract       Date:  2016 Jan-Mar

Review 8.  Emerging Progress in Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum: Challenges and Opportunities.

Authors:  Chuan Liu; Guo Zhao; Danni Qiao; Lintao Wang; Yeling He; Mingge Zhao; Yuanyuan Fan; Enshe Jiang
Journal:  Front Med (Lausanne)       Date:  2022-01-10

9.  Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial.

Authors:  Young-Chul Yoo; Sun-Joon Bai; Ki-Young Lee; Seokyung Shin; Eun Kyeong Choi; Jong Whax Lee
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.